These findings suggest the potential clinical utility of reversing intestinal dysbiosis and repairing acquired immune defects in PC patients.
No takes yet. Share an insight, caveat, or question.
Terrisse et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: